Pfizer Inc. (PFE)

Acerca de Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Al 3 de noviembre de 2026, la acción de Pfizer Inc. (PFE) avanzó ligeramente a $30.67, un alza de 0.49% (+$0.15) frente al cierre anterior. En la sesión, las acciones han operado entre $30.20 y $31.04. Eso ubica a PFE cerca del máximo de su rango de 52 semanas, de $23.62 a $31.04. Pfizer Inc. opera en el sector de pharmaceutical preparations y tiene una capitalización de mercado de aproximadamente $174.81 mil millones, con cerca de 50.82 millones de acciones negociadas.

Últimas noticias de PFE

• Pfizer Hikes Guidance On Solid Third Quarter, Names Company Vet As New CFOYahoo Finance· 3 nov, 8:27 a.m. ET
• Earnings from AMD and Pfizer plus labor market data: What to WatchYahoo Finance· 3 nov, 8:00 a.m. ETAMDJOLTS
• Pfizer (NYSE:PFE) reports strong Q3 2026, full-year outlook slightly exceeds expectationsYahoo Finance· 3 nov, 7:30 a.m. ET
• Pfizer increases annual profit forecast amid solid demand for blood thinner drugYahoo Finance· 3 nov, 7:22 a.m. ET
• Pfizer Finds Life Beyond the Pandemic as Earnings Top EstimatesYahoo Finance· 3 nov, 7:20 a.m. ET
• Pfizer (PFE) Surpasses Q3 Earnings and Revenue EstimatesYahoo Finance· 3 nov, 7:00 a.m. ET
• Pfizer Just Gained 12% in a Month to a 52-Week High: Take Profits, or Buy More?tikr.com· 3 nov, 6:59 a.m. ET
• Pfizer: Q3 Earnings SnapshotYahoo Finance· 3 nov, 6:53 a.m. ETAP

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de PFE en un solo lugar? Crea una cuenta gratis →

• @KryptonResearch14 yeah that footnote is the interesting part imo on $PFE. 4.0 billion through 2029 with only 1.2 billion spent so far means most of that margin cleanup is still ahead, not behind. if the next phase lands clean, does the guidance raise start looking conservativ…

  @BiotechSwings· 3 nov, 9:01 a.m. ET

• $PFE good vibes today

  @smartfellar· 3 nov, 9:00 a.m. ET

• $PFE the guidance raise got the headline, the next cost program got a footnote. The Q3 10-Q says the next phase of manufacturing optimization carries about 4.0 billion dollars of one time costs through 2029, roughly 60 percent non cash write downs and accelerated depreciation,…

  @KryptonResearch14· 3 nov, 8:59 a.m. ET

• $PFE let’s come out with a share buy back

  @KevinohWarsh· 3 nov, 8:53 a.m. ET

• $ELTP getting serious about M&A over here $SPY $TEVA $PFE

  @DoubleUpwithChuck· 3 nov, 8:51 a.m. ET· Alcista

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →